DONATE

Successful conclusion of the third EMBL-IBEC conference

The third edition of the EMBL-IBEC conference organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) focused on emerging and advanced therapies, bringing together around 150 international experts in the field of bioengineering last week at the PRBB in Barcelona.

Pere Roca-Cusachs receives ICREA Acadèmia program distinction for the second time

IBEC researcher Pere Roca-Cusachs has been awarded the “ICREA Academia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). The leader of IBEC’s Cellular and Molecular Mechanobiology group received the award in the Life & Medical Sciences category.

A study led by IBEC successfully mimics the complex neuroblastoma vasculature on a chip to explore treatments for this pediatric cancer

Two studies led by IBEC have successfully mimicked the transdifferentiation process of the neuroblastoma vasculature in in vitro models. These models, one in 2D and the other on a microfluidic chip, provide platforms for identifying new biomarkers and designing effective therapies against this type of cancer.

IBEC and ICMS reunite once more at their Annual Collaborative Symposium

Today, on March 14th, the joint ICMS-IBEC symposium took place. This event was co-organized by IBEC and the Institute for Complex Molecular Systems (ICMS). Throughout the conference, researchers from both IBEC and ICMS presented their areas of research, aiming to enhance the scientific collaboration between the two institutions.

IBEC and AEFAT join forces against ataxia telangiectasia

Today, the event “Advances in Ataxia Telangiectasia” took place, organized by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with AEFAT, the Spanish ataxia-telangiectasia family association. The gathering brought together patients’ families, researchers, and clinicians to explore the latest advancements in the clinical management of ataxia telangiectasia.